Advances in evidence-based cancer adoptive cell therapy.


Adoptive cell therapy (ACT) has been developed in cancer treatment by transferring/infusing immune cells into cancer patients, which are able to recognize, target, and destroy tumor cells. Recently, sipuleucel-T and genetically-modified T cells expressing chimeric antigen receptors (CAR) show a great potential to control metastatic castration-resistant… (More)
DOI: 10.21037/cco.2017.02.07


Cite this paper

@article{Ge2017AdvancesIE, title={Advances in evidence-based cancer adoptive cell therapy.}, author={Chunlei Ge and Ruilei Li and Xin Song and S K Qin}, journal={Chinese clinical oncology}, year={2017}, volume={6 2}, pages={18} }